Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) reported a net profit attributable to shareholders of 105.6 million yuan for the quarter ended Sept. 30, a 13.13% decrease from the prior-year period, according to a Friday filing with the Hong Kong bourse.
Earnings per share were 0.45 yuan, an 11.76% drop from a year ago.
The revenue for the quarter was 670.4 million yuan, 0.22% more than the previous year's quarter.
The company's shares were down by almost 11% in recent trading.
Price (HKD): $30.25, Change: $-3.7, Percent Change: -10.77%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。